The parents of a 21-year-old woman with a heart condition who died after consuming a heavily caffeinated energy drink at a Panera Bread location have filed a wrongful death suit against the renowned restaurant chain. They alleged that their daughter may have mistaken the beverage for regular lemonade.
The lawsuit, filed in Philadelphia, seeks compensatory and punitive damages, reports CNN.
Medical Examiner's Determination and Pre-Existing Condition
In September 2022, Sarah Katz suffered cardiac arrest after consuming Panera's "Charged Lemonade" while dining with friends. Despite prompt transportation to the hospital, she experienced a second arrest and ultimately succumbed to her condition.
According to the autopsy report obtained from a reliable source, the cause of death was attributed to cardiac arrhythmia resulting from long QT syndrome (LQTS). Sarah had been diagnosed with LQTS at a young age and managed her symptoms through medication and caffeine restriction, the lawsuit specifies, according to NBC.
Misleading Marketing and Inadequate Labeling
Many energy drinks contain substantial amounts of caffeine, added sugars, B vitamins, and other legal stimulants. Panera's "Charged Lemonade" is no exception, with ingredients like sugar, caffeine, coffee extract, and guarana extract, all of which contribute to its caffeine content.
The lawsuit contends that Panera failed to appropriately label the "Charged Lemonade" as an energy drink, causing significant consumer confusion. Panera's marketing materials touted the product as "Plant-based and Clean with as much caffeine as our Dark Roast Coffee." However, details regarding the equivalence between the Dark Roast coffee and the Charged Lemonade were omitted, leading to ambiguity and misinformation.
Online, Panera claims that its "Charged Lemonade" contains a comparable level of caffeine to its Dark Roast coffee. A large-sized Charged Lemonade served in a 30-ounce cup packs approximately 390 mg of caffeine.
The U.S. Food and Drug Administration recommends a daily caffeine intake of up to 400 milligrams for healthy adults, equating to around four or five cups of coffee.
Uncontrolled Caffeine Content in In-House Mixing
Panera's "Charged Lemonade" is prepared in-house by store employees, implying a lack of control over its caffeine content. This unregulated preparation method presents inherent dangers and the potential for considerable variation, making it difficult for consumers to assess their caffeine intake accurately.
Legal Action for Greater Responsibility
The lawsuit against Panera aims to seek justice for Sarah Katz and prompt responsible marketing practices across the industry.
"We want to make sure that the drink includes a warning, or is taken off the shelf," Elizabeth Crawford, the attorney representing Katz's parents, said. "It's a dangerous energy drink and it's not advertised that way. We want to make sure this does not happen to someone else."


Bayer’s Stroke Drug Achieves Breakthrough Trial Results, Boosting Market Confidence
U.S. and Rwanda Sign $228 Million Health Partnership to Boost Self-Reliance
Novo Nordisk and Eli Lilly Lower Prices for Weight-Loss Drugs Amid U.S. Agreement
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
ANZ Faces Legal Battle as Former CEO Shayne Elliott Sues Over A$13.5 Million Bonus Dispute
SK Hynix Considers U.S. ADR Listing to Boost Shareholder Value Amid Rising AI Chip Demand
U.S. Experts to Reassess Newborn Hepatitis B Vaccination Guidelines Amid Growing Debate
United Airlines Tokyo-Bound Flight Returns to Dulles After Engine Failure
SpaceX Insider Share Sale Values Company Near $800 Billion Amid IPO Speculation
Canada Loses Measles-Free Status After Nearly 30 Years Amid Declining Vaccination Rates
Eli Lilly Becomes First Pharma Giant to Hit $1 Trillion Amid Soaring Weight-Loss Drug Demand
Innovent’s Xinermei Intensifies Weight-Loss Drug Battle in China
Moore Threads Stock Slides After Risk Warning Despite 600% Surge Since IPO 



